GGrantIndex
Sort

141,003 grants matching cytokine

ALZHEIMER'S DISEASE AND ANIMAL MODELS

$990,000
Johns Hopkins University · P50 · FY2004 · AG

Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders

$989,897
Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer

$989,826
Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2021 · CA

Vaccine Strategies for Candidal Infections

$989,750
John P Hennessey · Novadigm Therapeutics, Inc. · R42 · FY2009 · AI

Epigenetic control by cytokines

$989,550
Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Cytokines in AIDS and Cancer Immunotherapy

$989,274
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Characterization And Functional Significance Of P450 Arachidonate Epoxygenases

$989,244
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice

$989,244
Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation

$988,980
Timothy S McConnell · Isoplexis, Inc. · R44 · FY2020 · CA

Studies Of Central Nervous System Functional Anatomy

$988,963
Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2010 · MH

Novel immunotherapy against MOG antibody disease

$988,943
Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2025 · TR

Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease

$988,920
Ali Keshavarzian · Rush University Medical Center · RC2 · FY2009 · AA

Development of Coccidioides Cytokine Release Assay

$988,914
Eric Holbrook · Miravista Diagnostics, Llc · R44 · FY2025 · AI

Anti-HIV Microbicide: Cellulose Acetate Phthalate (CAP)

$988,856
New York Blood Center · P01 · FY2001 · HD

Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases

$988,840
Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2021 · AI

Macrophage Polarization in Response to Infections and Inflammation

$988,702
Pradipta Ghosh · University Of California, San Diego · R01 · FY2021 · AI

Path to Commercialization of the first “off the shelf” T cell product

$988,677
Sunitha Kakarla · Viracyte, Llc · R44 · FY2017 · HL

Development of Synthetic High-Density Lipoproteins for Treatment of Sepsis

$988,469
Elke Lipka · Tsrl, Inc. · R44 · FY2022 · GM

InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation

$988,414
Bill Thelin · Altis Biosystems, Inc. · R44 · FY2023 · TR

A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1

$988,360
Erol Fikrig · L2 Diagnostics, Llc · R42 · FY2022 · AI

Opiate drug abuse and CNS vulnerability to HIV

$988,298
Kurt Francis Hauser · University Of Kentucky · P01 · FY2006 · DA

Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM)

$988,226
Charles Andrew Stewart · Cartesian Therapeutics, Inc. · R44 · FY2020 · CA

Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM)

$988,226
Charles Andrew Stewart · Cartesian Therapeutics, Inc. · R44 · FY2021 · CA

Xenobiotic Receptors

$988,205
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent

$988,000
Ke Zhang · Pacdna Llc · R42 · FY2024 · CA